Demetrio Gerace

1.2k total citations
25 papers, 959 citations indexed

About

Demetrio Gerace is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Demetrio Gerace has authored 25 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Demetrio Gerace's work include CAR-T cell therapy research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Demetrio Gerace is often cited by papers focused on CAR-T cell therapy research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Demetrio Gerace collaborates with scholars based in Italy and France. Demetrio Gerace's co-authors include Alessandro Allegra, Caterina Musolino, Andrea Alonci, Vanessa Innao, Giuseppa Penna, Sabina Russo, Salvatore Campo, Annamaria Petrungaro, Andrea Gaetano Allegra and Antonino Cannavò and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Haematology and Cancers.

In The Last Decade

Demetrio Gerace

22 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Demetrio Gerace Italy 14 555 285 218 155 130 25 959
Vanessa Innao Italy 20 642 1.2× 155 0.5× 453 2.1× 395 2.5× 216 1.7× 60 1.3k
Xiao Zhou China 19 544 1.0× 278 1.0× 195 0.9× 66 0.4× 56 0.4× 47 974
Xiaojing Cheng China 19 690 1.2× 312 1.1× 352 1.6× 46 0.3× 179 1.4× 57 1.3k
Davoud Rostamzadeh Iran 16 420 0.8× 183 0.6× 149 0.7× 44 0.3× 264 2.0× 35 1.0k
Tamer E. Fandy United States 18 874 1.6× 103 0.4× 213 1.0× 318 2.1× 91 0.7× 37 1.2k
Teng Yu China 18 496 0.9× 139 0.5× 177 0.8× 35 0.2× 107 0.8× 47 906
Baoan Chen China 21 514 0.9× 103 0.4× 239 1.1× 480 3.1× 181 1.4× 90 1.2k
D Chauhan India 8 1.1k 2.1× 148 0.5× 563 2.6× 675 4.4× 134 1.0× 29 1.6k
Peng Zou China 13 644 1.2× 256 0.9× 208 1.0× 115 0.7× 125 1.0× 25 1.1k
Wenbin Song China 19 540 1.0× 213 0.7× 245 1.1× 56 0.4× 80 0.6× 36 985

Countries citing papers authored by Demetrio Gerace

Since Specialization
Citations

This map shows the geographic impact of Demetrio Gerace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demetrio Gerace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demetrio Gerace more than expected).

Fields of papers citing papers by Demetrio Gerace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demetrio Gerace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demetrio Gerace. The network helps show where Demetrio Gerace may publish in the future.

Co-authorship network of co-authors of Demetrio Gerace

This figure shows the co-authorship network connecting the top 25 collaborators of Demetrio Gerace. A scholar is included among the top collaborators of Demetrio Gerace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demetrio Gerace. Demetrio Gerace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alati, Caterina, Gaetana Porto, Mark Greve, et al.. (2025). SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma. Cancers. 17(21). 3471–3471.
2.
Badagliacca, Roberto, et al.. (2025). Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted Therapy. International Journal of Molecular Sciences. 26(19). 9700–9700.
3.
4.
Martino, Massimo, et al.. (2023). Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?. International Journal of Molecular Sciences. 24(2). 1045–1045. 4 indexed citations
5.
Allegra, Alessandro, et al.. (2018). The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention. European Journal of Internal Medicine. 53. 12–20. 16 indexed citations
6.
Allegra, Alessandro, Alessandro Allegra, Vanessa Innao, et al.. (2018). Nanobodies and Cancer: Current Status and New Perspectives. Cancer Investigation. 36(4). 221–237. 25 indexed citations
7.
Allegra, Alessandro, Alessandro Allegra, Vanessa Innao, et al.. (2017). Telomerase and telomere biology in hematological diseases: A new therapeutic target. Leukemia Research. 56. 60–74. 20 indexed citations
8.
Innao, Vanessa, Alessandro Allegra, Alessandro Allegra, et al.. (2017). Standardisation of minimal residual disease in multiple myeloma. European Journal of Cancer Care. 26(6). e12732–e12732. 10 indexed citations
9.
Allegra, Alessandro, et al.. (2016). Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells. Blood Cells Molecules and Diseases. 62. 49–63. 35 indexed citations
10.
Allegra, Alessandro, Andrea Alonci, Giuseppa Penna, et al.. (2014). The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets. Cancer Investigation. 32(9). 470–495. 66 indexed citations
11.
Campo, Salvatore, Alessandro Allegra, Angela D’Ascola, et al.. (2014). MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma. British Journal of Haematology. 165(6). 801–813. 19 indexed citations
12.
Gangemi, Sebastiano, Alessandro Allegra, Mirella Profita, et al.. (2013). Decreased Plasma Levels of IL-33 Could Contribute to the Altered Function of Th2 Lymphocytes in Patients with Polycythemia Vera and Essential Thrombocythemia. Cancer Investigation. 31(3). 212–213. 11 indexed citations
13.
Musolino, Caterina, Alessandro Allegra, Mirella Profita, et al.. (2013). Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. Acta Haematologica. 131(3). 165–166. 10 indexed citations
14.
Allegra, Alessandro, Andrea Alonci, Demetrio Gerace, et al.. (2013). New orally active proteasome inhibitors in multiple myeloma. Leukemia Research. 38(1). 1–9. 61 indexed citations
15.
Musolino, Caterina, Alessandro Allegra, Antonella Saija, et al.. (2012). Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clinical Biochemistry. 45(16-17). 1439–1443. 37 indexed citations
16.
Gangemi, Sebastiano, Alessandro Allegra, Elisabetta Pace, et al.. (2012). Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia. Cellular Immunology. 278(1-2). 91–94. 12 indexed citations
17.
Allegra, Alessandro, Andrea Alonci, Salvatore Campo, et al.. (2012). Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). International Journal of Oncology. 41(6). 1897–1912. 299 indexed citations
18.
Penna, Giuseppa, Alessandro Allegra, Andrea Alonci, et al.. (2010). MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. Medical Oncology. 28(4). 1549–1554. 25 indexed citations
19.
Allegra, Alessandro, Emanuela Sant’Antonio, Giuseppa Penna, et al.. (2010). Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. European Journal Of Haematology. 86(2). 93–110. 43 indexed citations
20.
Allegra, Alessandro, Andrea Alonci, Giacomo Bellomo, et al.. (2010). Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. Leukemia & lymphoma. 52(1). 101–107. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanessa Innao Breakdown of academic impact, for papers by Xiao Zhou Breakdown of academic impact, for papers by Xiaojing Cheng Breakdown of academic impact, for papers by Davoud Rostamzadeh Breakdown of academic impact, for papers by Tamer E. Fandy Breakdown of academic impact, for papers by Teng Yu Breakdown of academic impact, for papers by Baoan Chen Breakdown of academic impact, for papers by D Chauhan Breakdown of academic impact, for papers by Peng Zou Breakdown of academic impact, for papers by Wenbin Song
Rankless by CCL
2026